SUPERNUS PHARMACEUTICALS, INC. (SUPN) Operating margin 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) operating margin by fiscal year — reported operating income divided by reported revenue.
-8.7%FY2025 · since FY2016: 25.2% → -8.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.7% | -21.0 pp |
| FY2024 | 12.3% | +13.2 pp |
| FY2023 | -0.9% | -7.8 pp |
| FY2022 | 6.9% | -7.9 pp |
| FY2021 | 14.8% | -18.5 pp |
| FY2020 | 33.4% | -4.4 pp |
| FY2019 | 37.8% | +2.5 pp |
| FY2018 | 35.3% | +2.4 pp |
| FY2017 | 32.9% | +7.7 pp |
| FY2016 | 25.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice